Giorgio Limoncella
Overview
Explore the profile of Giorgio Limoncella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Limoncella G, Grilli L, Dreassi E, Rampichini C, Platt R, Gini R
Am J Epidemiol
. 2024 Oct;
PMID: 39475077
In epidemiological database studies, the occurrence of an event is measured with error through an indicator whose specificity is often maximised, at the expense of sensitivity. However, if the indicator...
2.
Hurley E, Geisler B, Lupattelli A, Poblador-Plou B, Lassalle R, Jove J, et al.
Eur J Clin Pharmacol
. 2024 Feb;
80(5):707-716.
PMID: 38347228
Purpose: The COVID-19 pandemic has impacted medication needs and prescribing practices, including those affecting pregnant women. Our goal was to investigate patterns of medication use among pregnant women with COVID-19,...
3.
Duran C, Riera-Arnau J, Abtahi S, Pajouheshnia R, Hoxhaj V, Gamba M, et al.
Front Pharmacol
. 2023 Sep;
14:1207976.
PMID: 37663263
In March 2018, the European pregnancy prevention programme for oral retinoids was updated as part of risk minimisation measures (RMM), emphasising their contraindication in pregnant women. To measure the impact...
4.
Abtahi S, Pajouheshnia R, Duran C, Riera-Arnau J, Gamba M, Alsina E, et al.
Drug Saf
. 2023 Jun;
46(7):689-702.
PMID: 37294532
Introduction: Due to established teratogenicity of valproates, the EU risk minimisation measures (RMMs) with a pregnancy prevention programme (PPP) for valproate were updated in March 2018. Objectives: To investigate the...